메뉴 건너뛰기
Blood
Volumn 120, Issue 8, 2012, Pages 1535-1536
ATRA plus arsenic gets another "A" in APL
Author keywords

[No Author keywords available]
Indexed keywords

ARSENIC TRIOXIDE; IDARUBICIN; METHOTREXATE; RETINOIC ACID;
EID: 84865425902     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-07-439547     Document Type: Note
Times cited : (4)
References (10)
  • 1
    • 84865427746 scopus 로고    scopus 로고
    • All-transretinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
    • Iland HJ, Bradstock K, Supple SG, et al. All-transretinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood. 2012;120(8):1570-1580.
    • (2012) Blood , vol.120 , Issue.8 , pp. 1570-1580
    • Iland, H.J.1    Bradstock, K.2    Supple, S.G.3
  • 2
    • 0001837016 scopus 로고    scopus 로고
    • Treatment of 72 cases of acute promyelocytic leukemia with intravenous arsenic trioxide
    • Zhang P, Wang SY, Hu LH, et al. Treatment of 72 cases of acute promyelocytic leukemia with intravenous arsenic trioxide. Chin J Hematol. 1996;17(2):58-62.
    • (1996) Chin J Hematol , vol.17 , Issue.2 , pp. 58-62
    • Zhang, P.1    Wang, S.Y.2    Hu, L.H.3
  • 4
    • 77956251955 scopus 로고    scopus 로고
    • Singleagent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: Long-term follow-up data
    • Mathews V, George B, Chendamarai E, et al. Singleagent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data. J Clin Oncol. 2010;28(12):3866-3871.
    • (2010) J Clin Oncol , vol.28 , Issue.12 , pp. 3866-3871
    • Mathews, V.1    George, B.2    Chendamarai, E.3
  • 5
    • 79960225126 scopus 로고    scopus 로고
    • Phase II study of single-agent arsenic trioxide for the frontline therapy of acute promyelocytic leukemia
    • Ghavamzadeh A, Alimoghaddam K, Rostami S, et al. Phase II study of single-agent arsenic trioxide for the frontline therapy of acute promyelocytic leukemia. J Clin Oncol. 2011;29(20):2753-2757.
    • (2011) J Clin Oncol , vol.29 , Issue.20 , pp. 2753-2757
    • Ghavamzadeh, A.1    Alimoghaddam, K.2    Rostami, S.3
  • 6
    • 77949889670 scopus 로고    scopus 로고
    • Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia
    • Gore SD, Gojo I, Sekeres MA, et al. Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia. J Clin Oncol. 2010;28(6):1047-1053.
    • (2010) J Clin Oncol , vol.28 , Issue.6 , pp. 1047-1053
    • Gore, S.D.1    Gojo, I.2    Sekeres, M.A.3
  • 7
    • 77958456360 scopus 로고    scopus 로고
    • Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
    • Powell BL, Moser B, Stock W, et al. Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood. 2010;116(19):3751-3757.
    • (2010) Blood , vol.116 , Issue.19 , pp. 3751-3757
    • Powell, B.L.1    Moser, B.2    Stock, W.3
  • 8
    • 62549083523 scopus 로고    scopus 로고
    • Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
    • Hu J, Liu YF,WuCF, et al. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 2009;106(9):3342-3347.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , Issue.9 , pp. 3342-3347
    • Hu, J.1    Liu, Y.F.2    Wu, C.F.3
  • 9
    • 59149089411 scopus 로고    scopus 로고
    • Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin
    • Ravandi F, Estey E, Jones D, et al. Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin. J Clin Oncol. 2009;27(4):504-510.
    • (2009) J Clin Oncol , vol.27 , Issue.4 , pp. 504-510
    • Ravandi, F.1    Estey, E.2    Jones, D.3
  • 10
    • 79955991053 scopus 로고    scopus 로고
    • AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: Very long-term results and role of maintenance
    • Avvisati G, Lo-Coco F, Paoloni FP, et al. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance. Blood. 2011;117(18):4716-4725.
    • (2011) Blood , vol.117 , Issue.18 , pp. 4716-4725
    • Avvisati, G.1    Lo-Coco, F.2    Paoloni, F.P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.